We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Oxidative DNA damage by N4-hydroxycytidine, a metabolite of the SARS-CoV-2 antiviral molnupiravir.
- Authors
Kobayashi, Hatasu; Mori, Yurie; Ahmed, Sharif; Hirao, Yuichiro; Kato, Shinya; Kawanishi, Shosuke; Murata, Mariko; Oikawa, Shinji
- Abstract
Molnupiravir is an antiviral agent recently used for treating COVID-19. Here, we demonstrate that N4-hydroxycytidine (NHC), a molnupiravir metabolite, treated with cytidine deaminase (CDA) induced Cu(II)-mediated oxidative DNA damage in isolated DNA. A colorimetric assay revealed hydroxylamine generation from CDA-treated NHC. The site specificity of DNA damage also suggested involvement of hydroxylamine in the damage. Furthermore, Cu(I) and H2O2 play an important role in the DNA damage. We propose oxidative DNA damage via CDA-mediated metabolism as a possible mutagenic mechanism of NHC, highlighting the need for careful risk assessment of molnupiravir use in therapies for viral diseases including COVID-19.
- Subjects
DNA damage; MOLNUPIRAVIR; CYTIDINE deaminase; COVID-19; SARS-CoV-2
- Publication
Journal of Infectious Diseases, 2023, Vol 227, Issue 9, p1068
- ISSN
0022-1899
- Publication type
journal article
- DOI
10.1093/infdis/jiac477